$12.06
0.231.94%
At close: Dec 9, 4:00 PM EST
$12.10
0.040.33%
After Hours: 4:03 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bioage Labs (BIOA) stock?
You can purchase shares of Bioage Labs (NASDAQ:BIOA) through any online brokerage.
Who are Bioage Labs (BIOA) competitors?
Other companies in Bioage Labs’s space includes: Atea Pharmaceuticals Inc (NASDAQ:AVIR), MediWound Ltd (NASDAQ:MDWD), Zevra Therapeutics Inc (NASDAQ:ZVRA), SNDL Inc (NASDAQ:SNDL) and Neumora Therapeutics Inc (NASDAQ:NMRA).
What is the forecast, or price target, for Bioage Labs (BIOA) stock?
Bioage Labs has a consensus price target of $11.33.
What is the current price for Bioage Labs (BIOA)?
The stock price for Bioage Labs (NASDAQ: BIOA) is $12.1 last updated December 9, 2025 at 4:03 PM EST.
Does Bioage Labs (BIOA) pay a dividend?
There are no upcoming dividends for Bioage Labs.
When is Bioage Labs (NASDAQ:BIOA) reporting earnings?
Bioage Labs does not have any upcoming earnings scheduled.
Is Bioage Labs (BIOA) going to split?
There is no upcoming split for Bioage Labs.
What sector and industry does Bioage Labs (BIOA) operate in?
Bioage Labs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
